Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates.
about
Efflux-mediated drug resistance in bacteria: an updateXenobiotic efflux in bacteria and fungi: a genomics updateMolecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I)Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006)Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.Deciphering the distance to antibiotic resistance for the pneumococcus using genome sequencing dataAntimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003.Efflux pumps as antimicrobial resistance mechanisms.Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002.Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolidesStaphylococcus efflux msr(A) gene characterized in Streptococcus, Enterococcus, Corynebacterium, and Pseudomonas isolatesMacrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants.Induction of efflux-mediated macrolide resistance in Streptococcus pneumoniaeApplication of molecular genetic methods in macrolide, lincosamide and streptogramin resistance diagnostics and in detection of drug-resistant Mycobacterium tuberculosis.Efflux-mediated antimicrobial resistance.Predictive computational phenotyping and biomarker discovery using reference-free genome comparisons.Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES StudyComposite structure of Streptococcus pneumoniae containing the erythromycin efflux resistance gene mefI and the chloramphenicol resistance gene catQ.Drug Resistance Characteristics and Macrolide-Resistant Mechanisms of Streptococcus pneumoniae in Wenzhou City, China.Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006Incidence of pediatric invasive pneumococcal disease in the Island of Majorca (2008-2010), an area with non-universal vaccination, and estimations of serotype & children population coverage by available conjugate vaccinesGenetic elements responsible for erythromycin resistance in streptococci.The mef(E)-carrying genetic element (mega) of Streptococcus pneumoniae: insertion sites and association with other genetic elements.Resistance to Macrolide Antibiotics in Public Health Pathogens.Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors.DNA methylase activity as a marker for the presence of a family of phage-like elements conferring efflux-mediated macrolide resistance in streptococci.Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.Ureaplasma parvum undergoes selection in utero resulting in genetically diverse isolates colonizing the chorioamnion of fetal sheep.Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae.Human antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae.Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible.Antibiotic resistance ABCF proteins reset the peptidyl transferase centre of the ribosome to counter translational arrest.
P2860
Q24609407-675C17E1-D352-4E60-B3D3-B6C5103A6055Q28834633-FD99E2B3-3535-417D-B60B-97FD0C6F72C8Q31020451-079F6641-138A-49A7-ADCD-EA45B907C5E2Q31098523-D8563087-EDD5-45FA-B63E-FFA6ECC91798Q31139606-89A05E0C-F4AD-40E9-9726-3A76E3DD1B6FQ31162440-A86E3900-2E29-4F0D-8A74-25723820E98FQ33883600-1240B366-3931-4E79-922C-479548EC9732Q34003782-16D345E4-961E-493B-B5D4-CCC292D9CA3FQ34076998-48BE4D79-393D-4401-ADB2-1329BDB06174Q34123790-77B24202-61C3-4435-BE6C-F84AD41E9A1CQ34509723-271128A9-1502-4807-9BE8-F87BBCB138F6Q34648637-E139509D-F44E-4A16-9350-BBA999DB796DQ35065806-3FCFE50B-8805-463D-9854-D65C98454583Q36003067-6C7FFC10-3847-429C-B0AF-A1401A1BD0EBQ36138147-7E2A6C95-7D23-4054-B946-6764A0315E5EQ36145457-BBB5E00B-5A9E-49C9-A0C4-76DC1C39CF0DQ36266462-72206943-3EBE-4998-A936-DC5A08C20CB2Q36295426-2A8B20CB-7ED0-4DD1-91B8-BC11D8F646C9Q37152559-254C4192-BE58-44DB-8D2E-5E2D205BBE5EQ37190726-BA13ED99-99B4-484B-AD0F-64FD4044E407Q37305101-C7EC4821-A47F-44EA-A8C5-ACA54FFC595FQ37322929-D5AE7843-D927-41B3-9397-ED03BF721B63Q38665301-95A62BA7-4205-4AEA-9AE6-88CE13C4F124Q38928353-E1950D56-1DA9-46F7-B9E0-B8DE082C5EFAQ39021961-E35AAC65-A623-4A5B-84DC-2DE4CD7FEA4DQ39077279-90D0E4A4-2F8C-4050-B5E7-4F1A63D9D0B1Q42059412-F46FC592-BA6F-44A6-816F-A33623A5F24BQ42236874-59155D31-00B3-4E91-9B6A-A0D291701F87Q42273994-9F7EDF7D-D937-439E-BD8F-1A9A093B3D39Q42279020-44E31C49-7C5C-4BED-9FE0-FFFD95A6F139Q42564810-041AE121-CB30-4EF6-982D-A51B288D713EQ50132954-73C13B08-E67D-4A63-9D44-F797F888D79C
P2860
Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Characterization and prevalenc ...... pneumoniae clinical isolates.
@en
Characterization and prevalenc ...... pneumoniae clinical isolates.
@nl
type
label
Characterization and prevalenc ...... pneumoniae clinical isolates.
@en
Characterization and prevalenc ...... pneumoniae clinical isolates.
@nl
prefLabel
Characterization and prevalenc ...... pneumoniae clinical isolates.
@en
Characterization and prevalenc ...... pneumoniae clinical isolates.
@nl
P2093
P2860
P1476
Characterization and prevalenc ...... pneumoniae clinical isolates.
@en
P2093
Dee Shortridge
Melissa M Daly
Stella Doktor
P2860
P304
P356
10.1128/JCM.42.8.3570-3574.2004
P407
P577
2004-08-01T00:00:00Z